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Abstract
Background: Relapsing fever (RF) is an acute infectious disease caused by arthropod-borne spirochetes of the
genus Borrelia. The disease is characterized by recurrent episodes of fever that concur with spirochetemia. The RF
borrelioses include louse-borne RF caused by Borrelia recurrentis and tick-borne endemic RF transmitted by argasid
soft ticks and caused by several Borrelia spp. such as B. crocidurae, B. coriaceae, B. duttoni, B. hermsii, B. hispanica and
B. persica. Human infection with B. persica is transmitted by the soft tick Ornithodoros tholozani and has been
reported from Iran, Israel, Egypt, India, and Central Asia.
Methods: During 2003–2015, five cats and five dogs from northern, central and southern Israel were presented for
veterinary care and detected with borrelia spirochetemia by blood smear microscopy. The causative infective agent
in these animals was identified and characterized by PCR from blood and sequencing of parts of the flagellin (flab),
16S rRNA and glycerophosphodiester phosphodiestrase (GlpQ) genes.
Results: All animals were infected with B. persica genetically identical to the causative agent of human RF.
Phylogenetic analysis indicated that DNA sequences from these pet carnivores clustered together with B. persica
genotypes I and II from humans and O. tholozani ticks and distinctly from other RF Borrelia spp. The main clinical
findings in cats included lethargy, anorexia, anemia in 5/5 cats and thrombocytopenia in 4/5. All dogs were
lethargic and anorectic, 4/5 were febrile and anemic and 3/5 were thrombocytopenic. Three dogs were co-infected
with Babesia spp. The animals were all treated with antibiotics and the survival rate of both dogs and cats was
80 %. The cat and dog that succumbed to disease died one day after the initiation of antibiotic treatment, while
survival in the others was followed by the rapid disappearance of spirochetemia.
Conclusions: This is the first report of disease due to B. persica infection in cats and the first case series in dogs.
Infection was associated with anemia and thrombocytopenia. Fever was more frequently observed in dogs than
cats. Domestic canines and felines suffer from clinical disease due to B. persica infection and may also serve as
sentinels for human infection.
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Background
Relapsing fever (RF) is an acute infectious disease
caused by arthropod-borne spirochetes of the genus
Borrelia. The disease in humans is characterized by
recurrent episodes of fever, which usually concur with
spirochetemia and is considered from a historical per-
spective the first disease linked to a specific microbial
causative infectious agent [1]. The RF borrelioses can
be grouped into two forms: louse-borne epidemic RF
caused by B. recurrentis and tick-borne endemic RF
commonly transmitted by argasid soft ticks with the
exception of Borrelia miyamotoi, transmitted by sev-
eral species of Ixodes hard ticks [2, 3].
Human infection with B. persica also known as Per-
sian RF has been reported from Iran, Israel, Egypt,
Pakistan, and former USSR Asian republics including
Uzbekistan [4–8].
B. persica is transmitted by the soft tick Ornithodoros
tholozoni whose distribution includes the Middle East,
Central Asia and Northern India [9]. Ornithodoros tholo-
zani feeds on warm-blooded animals and commonly
lives in caves, ruins, rock crevices and man-made shel-
ters where livestock is housed [10]. Human RF borrelio-
sis is a reportable disease in Israel and the annual
incidence average in civilians declined from 0.35 cases
per 100,000 inhabitants from 1975 to 1985 to 0.11 cases
per 100,000 inhabitants from 1986 to 2003. However,
the incidence among Israeli soldiers is considerably
higher with an average of 6.4/100,000 persons [11]. Al-
though human RF borreliosis due to B. persica in the
Middle East is usually not associated with mortality, se-
vere infections with the acute respiratory syndrome and
fatal infections have been reported in Israel [12, 13].
Three different genotypes of B. persica have been de-
scribed from humans and O. tholozani ticks based on
DNA sequences of the flagellin (flaB) gene [9].
Disease in domestic animals due to RF borreliae was
rarely described. In this context, borreliosis with two spe-
cies of RF borreliae, B. turicatae and B. hermsii, has been
reported to cause disease in dogs in the USA [14–17].
Borrelia persica infection has recently been reported in a
young spirochetemic puppy from Iran [18]. However, to
our best knowledge no descriptions of disease caused by
RF borreliae have been reported in domestic felines except
for the isolation of B. persica from an Israeli cat, which is
one of the cases described in this study [19].
Methods
Naturally-infected animals
Spirochetemia was detected during microscopic examin-
ation of blood smears stained by Romanowsky staining so-
lutions from animals whose blood was submitted for a
complete blood count (CBC) to veterinary diagnostic la-
boratories in Israel or performed in-house by veterinarians
during the years 2003 to 2015. Blood anticoagulated in
EDTA from these animals was submitted for molecular
identification and genotyping to the Koret School of Vet-
erinary Medicine at the Hebrew University.
PCR and genetic analysis
DNA was extracted from 200 μl of EDTA-anticoagulated
blood samples from spirochetemic animals using the Illus-
tra blood genomicPrep Mini Spin Kit (GE Health care,
Buckinghamshire, UK), following the manufacturer’s in-
structions. PCRs were performed with primers targeting
three different genes of RF borreliae (Table 1). An ap-
proximately 515 bp fragment of the Borrelia 16S riboso-
mal RNA (16S rRNA) gene was amplified using primers
rec4 and rec9 as previously described [20]. An approxi-
mately 346 bp fragment of the flab gene was amplified
from extracted DNA samples as previously reported for
other Borrelia species using primers Bfpbu and Bfpcr [21],
and an approximately 212 bp fragment of the glyceropho-
sphodiester phosphodiesterase (GlpQ) gene, which is spe-
cific for RF borreliae, was amplified using primers 128f
and 340r [22]. DNA from a borrelia-negative dog and
from a human case of B. persica infection were used as
negative and positive controls, respectively. A non-
template negative control (NTC) was also included in
each PCR run. Positive DNA amplicons were purified
(EXO-Sap, New England Biolabs Inc., Ipswich, USA) and
sequenced in the Center for Genomic Analyses at the
Hebrew University (Jerusalem, Israel) using the BigDye
Terminator cycle from Applied Biosystems ABI3700 DNA
Analyzer. The ABI Data Collection and Sequence Analysis
software (ABI, Carlsbad, USA) was used for analysis. DNA
sequences were compared for similarities to other se-
quences in GenBank using the BLAST program hosted by
NCBI, National Institutes of Health, USA (http://
www.ncbi.nlm.nih.gov) and new DNA sequences from
Borrelia-infected dogs and cats were deposited in
GenBank.
PCRs for Ehrlichia canis and for Babesia spp. were
performed on DNA from the dog blood samples using
primers 16S-F and 16S-R and the Piroplasmid-F and
Piroplsamid-R primers, respectively, as previously
Table 1 Target genes and primers used for PCR to detect and
characterize Borrelia persica in blood samples from cats and
dogs
Target gene Primers Primer sequence (5’ to 3’) Reference
16S rRNA REC4 ATGCTAGAAACT GCATGA [20]
REC9 TCGTCTGAGTCCCCATCT
flab Bfpbu GCT GAA GAG CTTGGAATGCAACC [21]
Bfpcr TGATCAGTTATCATTCTAATAGCA
GlpQ 128f CAGAACATACCT TAGAAGCTCAAGC [22]
340r GTGATTTGATTTCTGCTAATGTG
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described [23, 24]. PCR for hemotrophic Mycoplasma
species was performed using primers HBT-F and HBT-R
as previously described [25]. Serology for feline leukemia
virus (FeLV) and for feline immunodeficiency virus
(FIV) was performed using a commercial assay (SNAP
FIV/FeLV Combo Test, IDEXX Laboratories, West-
brook, Maine, USA).
Phylogenetic analysis
A phylogenetic analysis, which included DNA sequences
from this study, was carried out to compare these se-
quences to other Borrelia spp. that had previously been
deposited in GenBank. Sequences were analyzed using
the MEGA version 6.1 (http://www.megasoftware.net/)
and phylogenetic trees were constructed by the max-
imum likelihood algorithms using the Tamura-3-
Parameter model [26]. Bootstrap replicates were per-
formed to estimate the node reliability, and values were
obtained from 1000 randomly selected samples of the
aligned sequence data.
Results
The demographic and clinical findings from the ten spir-
ochetemic cats and dogs are presented in detail in Ta-
bles 2 and 3. The five cats were from cities (Jerusalem
and Arad) and from rural villages (Kfar Adumim, Mat-
zuba and Kfar Oranim) in southern, central and north-
ern Israel and all had outdoor access. The five dogs were
all from small towns and villages (Yavne’el, Meitar,
Hashmonaim, Karmei Yosef and Amatzia) located also
in southern, central and northern Israel.
The five spirochetemic cats included three females and
two males with an age range of one to 7.5 years. Only
one of the cats had fever (> 39.0 °C). All four cats with
owners presented with lethargy and anorexia. Three of
the five cats had pale mucous membranes and two were
Table 2 Demographic and clinical characteristics of cats infected with Borrelia persica included in the study
Cat number (sample ID) 1 (6812) 2 (42798) 3 (9727) 4 (213813) 5 (8738)
Location Kfar Adumim Jerusalem Arad Matzuba Kfar Oranim
Year of diagnosis 2003 2003 2010 2012 2015
Outdoor access + + + + +; stray
Sex; age in years F; 2 M; 1 Male; ND F; 7.5 F; 1
Fever – – – - 39.8 °C
Lethargy + + + + ND
Anorexia + + + + ND
Pale mucous
membranes
– – + + +
Icterus – – + + -
Anemia + + + + +
Hematocrit L/L 0.208 0.116 0.113 0.109 0.270
MCV fL 40.5 42.1 31.2 39.3 ND
MCHC g/L 336 288 389 390 ND
Leukocytosis; WBC
number × 109/L
–; 11.6 –; 5.86 +; 33.88 +; 21.33 -; Est WNL
Thrombocytopenia;
PLT number × 109/L
+; 35 +; 119 –; 227 +; 71 +; Est low
Co-infection: PCR for
hemotrophic
Mycoplasma spp.
Serology FeLV; FIV
– – – - -
(–; –) (–; –) ND (-; +) (-; -)
Antibiotic treatment amoxicillin/clavulanic
acid
amoxicillin/
clavulanic
acid
long acting
tetracycline and
amoxicillin/
clavulanic acid
doxycycline doxycycline
Survival and response
to treatment
survived;
spirochetemia not
evident one day after
treatment initiation
died one
day after
treatment
initiation
survived survived; clinical improvement
reported 12 h after initial
doxycycline; clinical recovery
in 4 days
survived; recovered clinically
and no spirocehtemia evident
on follow-up 21 days after
treatment initiation
ND not determined, Est estimated from blood smear, WNL within normal limits; Hematocrit, reference range 0.277–0.468 L/L; MCV mean cell volume, range 41–
53 fL; MCHC mean corpuscular hemoglobin concentration, range 270–330 g/L; WBC white blood cells, range 6.3–19.6 × 109/l; PLT: platelets, range 156–626 × 109/l
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icteric. Blood for CBC was available from four cats (#1–4)
and only hematocrit and blood smear evaluation were
recorded from cat # 5. All cats were anemic (hematocrit <
0.277 L/L) with microcytic anemia in three cats.
Thrombocytopenia was evident in 4/5 cats (platelets < 156
× 109/l) and confirmed by blood smear evaluation, while
leukocytosis (> 19.6 × 109/l) was evident in 2/5. All cats
were negative for hemotrophic Mycoplasma species by
PCR. Four of the cats (#1, 2, 4 and 5) were tested for infec-
tion with FeLV and FIV and cat #4 was found positive for
FIV. Additional blood was not available to test cat # 3 for
infection with these retroviruses. All cats received anti-
biotic treatment; three were treated with amoxicillin/cla-
vulanic acid, two with doxycycline and one with a
combination of amoxicillin/clavulanic acid and long acting
injectable tetracycline. The cats that survived the infection
were treated for variable durations ranging from one to
four weeks. One cat (#2) died one day after treatment ini-
tiation, whereas the remaining four cats survived and re-
covered. Cat # 1 did not have evident spirochetemia when
evaluated by blood smear one day after treatment initi-
ation; the owners of cat # 4 reported a clinical improve-
ment twelve hours after initial antibiotic administration
and return to normal activity within four days; and cat #5
also recovered clinically rapidly and no spirochetemia was
detected on a follow-up 21 days after treatment initiation.
The five spirochetemic dogs included three males and
two females with an age range of 1.5 to 12.5 years. Four
Table 3 Demographic and clinical characteristics of dogs infected with Borrelia persica included in the study
Dog number
(sample ID)
1 (61887) 2 (8726) 3 (4663) 4 (9835) 5 (8692)
Location Yavne' el Meitar Hashmonaim Karmei Yosef Amatzia
Year of diagnosis 2003 2012 2012 2013 2015
Sex; age in years M; 1.5 F; 3 M; 4 F; 12.5 M; 2.5
Breed Siberian Husky Mixed breed Labrador Mixed breed German Shepherd
Fever 40.8 ° C 41.2 °C 39.5 °C –; (38.9 ° C) 39.4 °C
Lethargy + + + + +
Anorexia + + + + +
Pale mucous
membranes
– + + + -
Icterus – – + – -
Anemia + + + + -
Hematocrit L/L 0.271 0.340 0.189 0.270 0.375
MCV fL 75.3 77.7 66.7 69.2 67.5
MCHC g/l 305 305 337 353 381
Leukocytosis – – – – -
WBC number ×
109/l
10.69 11.80 12.80 9.13 7.70
Thrombocytopenia – + – + +
PLT number ×
109/l
168 41 171 86 39
Co-infection:
PCR for E. canis – – – – -
PCR for Babesia sp. – + + + -
Antibiotic
treatment
ciprofloxacin for
2 days and then
doxycycline
doxycycline long acting
tetracycline and
amoxicillin/
clavulanic acid
amoxicillin initially, continued
with doxycycline
doxycycline
Survival and
response to
treatment
survived; no
spirochetemia at
recheck 7 days
after treatment
initiation
survived; no spirochetemia
at recheck 11 days after
treatment initiation; treated
also with imidocarb
dipropionate for babesiosis
died one day after
treatment initiation
survived; improved a day after
initial treatment with amoxicillin;
treated also with imidocarb
dipropionate for babesiosis
survived; recovered
clinically at recheck
4 days after
treatment initiation
Hematocrit, reference range 0.371–0.57 L/L; MCV mean cell volume, range 58.8–71.2 fL; MCHC mean corpuscular hemoglobin concentration, range 310–362 g/l;
WBC white blood cells, range 5.2–13.9 × 109/L; PLT: platelets, range 150–400 × 109/l
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had fever (> 39.0 °C) and the other dog had a borderline
fever of 38.9 °C. All dogs presented lethargy and an-
orexia. Four of the five dogs had pale mucous mem-
branes and one was icteric. Four dogs were anemic
(hematocrit < 0.371 L/L) with macrocytic anemia in two.
Thrombocytopenia (< 150 ×109/l) was evident in three
animals. All dogs were negative for E. canis infection
tested by PCR and three (#2,3 and 4) were positive for
Babesia spp. by PCR and blood smear evaluation. All
dogs received antibiotic treatment: two were treated
with doxycycline alone, one with ciprofloxacin for two
days and then switched to doxycycline, another one re-
ceived a combination of long acting tetracycline and
amoxicillin/clavulanic acid, and one received amoxicillin
initially and was later switched to doxycycline. Two dogs
with babesiosis (#2 and 4) were treated also with imido-
carb dipropionate injections. The dogs that survived the
infection were treated with doxycycline for 21 days. One
dog (#3) co-infected with Babesia sp. died one day after
treatment initiation, whereas the four other dogs sur-
vived and fully recovered. Dogs #1 and #2 did not have
evident spirochetemia in their blood smears at recheck
seven and eleven days after treatment initiation, respect-
ively. In dogs #4 and #5, clinical improvement was noted
one and four days, respectively, after initial antibiotic
administration.
Numerous spirochetes were noted in blood smears
from all dogs and cats with 4 to 10 spirochetes per
microscopic field at 500× magnification (Fig. 1). Cat #2
which died in the course of infection had an overwhelm-
ingly high spirochetemia (Figs. 2 and 3) and blood ob-
tained from this cat was used for culture of B. persica as
previously described [19]. Spirochetes seen in the blood
smears occasionally formed aggregates with platelets
(Fig. 4) or encircled erythrocytes (Fig. 5).
PCR of blood from all cats and dogs was positive for
Borrelia sp. by all three PCR protocols amplifying frag-
ments of the 16S rRNA, flaB and GlpQ genes, except for
cat # 2. This animal was not tested with the GlpQ PCR,
because no further DNA was available for the test
(Table 4). DNA sequences amplified from all of the ani-
mals with the three PCR protocols were 99–100 % iden-
tical to B. persica sequences already deposited in
GenBank and B. persica was constantly the first match
in all BLAST searches. Twenty-nine DNA sequences
from this study were deposited in GenBank and assigned
accession numbers (Table 4).
The Babesia PCR products amplified by the Piroplas-
mid PCR from dogs #2, 3 and 4 yielded sequences that
differed from other known Babesia spp. in GenBank and
Fig. 1 Spirochetemia with Borrelia persica in a blood smear from
dog no. 4. Romanowsky stain. Scale-bar: 10 μM
Fig. 2 Prominent Borrelia persica spirochetemia in cat no. 2.
Romanowsky stain. Scale-bar: 20 microns
Fig. 3 Higher magnification of spirochetemia with Borrelia persica in
cat no. 2. Romanowsky stain. Scale-bar: 10 μM
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therefore were termed Babesia sp. in this study and
await further characterization.
Phylogenetic analysis of the flaB gene sequences
(Fig. 6) indicated that the sequences from the B. persica
infected dogs and cats clustered together with each
other and with sequences of other B. persica organisms
recovered from humans and O. tholozani ticks. Most of
the cat and dog sequences clustered together with a B.
persica genotype 1 sequence (DQ679907) from a human
individual, whereas one cat sequence clustered together
with a B. persica genotype 2 from a tick (DQ6795509),
while none of our sequences clustered closely with B.
persica genotype 3 from a human (DQ679906). All B.
persica sequences clustered separately from other Old
World RF Borrelia spp. including B. duttonii, B.
crociduare, B. hispanica and B. recurrentis. RF species
from the American continent including B. parkeri, B.
turicatae and B. hermsii also clustered separately and to-
gether with B. miyamotoi which was described from the
American continent and also from Asia and Europe.
Phylogenetic analysis of GlpQ sequences (Fig. 7) also
indicated that the sequences from the B. persica-infected
dogs and cats clustered together with each other and
with other B. persica sequences from a human and an O.
tholozani tick. As in the flaB phylogram, B. persica GlpQ
sequences clustered separately from Old World RF Bor-
relia spp. including B. hispanica, B. duttonii, B. croci-
durae and B. recurrentis. The Old World species
including B. persica also clustered separately from
American RF Borrelia spp. namely B. hermsii, B. parkeri
and B. turicatae.
Discussion
This study describes clinical disease associated with B.
persica infection in domestic cats and dogs. The infected
animals had profound spirochetemia, were lethargic, an-
orectic and suffered from anemia and frequent
thrombocytopenia. Infected dogs were febrile or border-
line febrile, whereas fever was noted in only one infected
cat. Treated dogs and cats mostly recovered rapidly with
antibiotic treatment, and spirochetemia apparently
cleared as found in follow up blood tests. Nevertheless,
the fact that two of the infected animals (20 %) had died
indicates that this disease is not benign and is potentially
fatal in pets. The Jarisch–Herxheimer reaction with
fever, sweating, anorexia and occasional death upon ini-
tiation of antibiotic treatment for RF borreliosis and bac-
terial decay, has been associated with the increase of
circulating levels of tumor necrosis factor α (TNF-α),
interleukin-6, and interleukin-8 in humans [27]. Death
due to a similar reaction may have occurred also in the
dog and cat in this study that died soon after the begin-
ning of antibiotic treatment. No evidence of cyclic spiro-
chetemia with relapsing episodes of fever, as shown in
infected people, was reported for the infected dogs and
cats. Yet, this may be due to the difficulty of getting a
thorough history on these pets, the possibility that the
infected animals were treated and not given the oppor-
tunity to develop recurrent fever episodes, which could
be recorded by their veterinarians, or simply due to lack
of close monitoring.
The only previous report of a dog with infection caused
by B. persica was described in a 2-week old puppy from
Teheran, Iran, presenting anorexia, pale mucous mem-
branes, diarrhea, vomiting and anemia [18]. Another spe-
cies, B. hispanica has been shown to experimentally infect
a dog by rat bite [28]. Two other species of RF borreliae
have been reported to infect dogs in North America. Dogs
with B. turicatae infection reported from Texas and
Fig. 4 Borrelia persica spirochetes aggregating with platelets in a
blood smear from dog no. 1. Romanowsky stain. Scale-bar: 10 μM
Fig. 5 Borrelia persica spirochete encircling a canine erythrocyte in
blood smear from dog no. 2. Romanowsky stain. Scale-bar: 10 μM
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Florida [14–16] were febrile, lethargic, anorectic, anemic
and thrombocytopenic. A single case of canine infection
with B. hermsii was reported from Washington State,
USA. This dog presented with lethargy, anorexia, fever,
anemia, leukopenia and thrombocytopenia [17]. These re-
ports from dogs infected with B. turicatae, B. hermsii and
the B. persica-infected puppy from Iran indicate that dif-
ferent RF Borrelia spp. are able to infect dogs with similar
clinical manifestations including lethargy, anorexia, fever,
anemia and thrombocytopenia.
Disease caused by B. persica does not seem to be fre-
quent in Israeli cats and dogs as the cases included in
Table 4 GenBank accession number of Borrelia persica from cats and dogs included in the study
Animal number 16S rRNA flagellin (flab) glycerophosphodiester phosphodiesterase (GlpQ)
Cat 1 (6812) DQ207601 KT895509 KT895516
Cat 2 (42798) DQ207603 DQ211356 ND
Cat 3 (9727) KT895504 KT895511 KT895518
Cat 4 (213813) KT895503 KT895510 KT895517
Cat 5 (8738) KU565880 KU565881 KU932019
Dog 1 (61887) DQ207600 DQ207604 KU932020
Dog 2 (8726) KT895505 KT895512 KT895519
Dog 3 (4663) KT895506 KT895513 KT895520
Dog 4 (9835) KT895507 KT895514 KT895521
Dog 5 (8692) KT895508 KT895515 KT895522
ND not done
Fig. 6 A maximum likelihood phylogram comparing 267 bp DNA sequences of the flaB gene from the cats and dogs included in the study to sequences
from other B. persica GenBank accessions and from other Borrelia spp. New sequences derived from this study are marked with black diamond squares.
Note the division into B. persica genotypes marked in Roman numerals. The GenBank accession numbers, species of infected host and country of origin
are included for each sequence. The Tamura-3-Parameter model was used in the construction of this phylogram and bootstrap values higher than 70 %
are indicated
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this series, although probably not the only cases of this
disease in Israel during the period of case collection, had
been recorded over a 12-year period. Furthermore, the
lack of apparent geographical clustering of cases and the
wide distribution of disease locations from the southern
part of the country to its north, suggests that infection is
sporadic.
The common treatment for human B. persica RF is
with doxycycline [29, 30] although treatment with
amoxicillin has also been recommended [9]. Doxy-
cycline is also recommended as the major drug for
post-exposure prevention [31, 32]. Although almost
all the dogs and cats in this study, which recovered
from disease were treated with doxycycline or an-
other tetracycline, cat #1 also recovered and was ap-
parently non-spirochetemic one day after treatment
initiation with amoxicillin and clavulanic acid,
whereas dog #4 was treated initially with amoxicillin,
reported to improve one day later, and only then
was continued with doxycycline. This suggests that
several antibiotics may be effective against B. persica
infection in cats and dogs. Nevertheless, due to the
apparent efficacy of doxycycline evident in this study
and based on the recommendation for human treat-
ment and prophylaxis with this drug [29, 31], it
would be sensible to recommend doxycycline as a
first line antibiotic for canine and feline B. persica
infection.
Co-infection with babesiosis potentially contributed to
the severity and clinical manifestations of B. persica infec-
tion in the three co-infected dogs. Canine babesiosis is
also associated with fever, anemia and thrombocytopenia
[33]. Nevertheless, the two dogs with no detectable
babesiosis were also febrile, thrombocytopenic (dog # 5)
or borderline thrombocytopenic (dog # 1) and anemic
(dog #1) or borderline anemic (dog #5). Thus, babesiosis
by itself cannot account for all the clinical findings in the
dogs with B. persica infection. Furthermore, no cats were
positive for hemotrophic mycoplasmas and only one of
the four cats tested for FeLV and FIV was positive for FIV
(#4). Therefore, no clear association of feline B. persica in-
fection with hemortophic Mycoplasma or immune-
suppressive viral infections such as FeLV and FIV is
apparent.
The genetic analysis of B. persica from cats and dogs
based on three different genes strongly suggests that the
pathogen from these animals is identical to the cause of
RF in humans in Israel and other countries. The B. per-
sica organisms detected in the animals belonged to two
of the three known B. persica genotypes described from
humans in Israel [5, 9]. Since the same infectious agent
exists in humans and domestic animals, the infection
Fig. 7 A maximum likelihood phylogram comparing 133 bp DNA sequences of the GlpQ gene from the cats and dogs included in the study to
sequences from other Borrelia persica GenBank accessions and from other Borrelia spp. New sequences derived from this study are marked with
black diamond squares. The GenBank accession numbers, species of infected host and country of origin are included for each sequence. The
Kimura-2-Parameter model was used in the construction of this phylogram and bootstrap values higher than 70 % are indicated
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and disease might be considered a zoonosis. Never-
theless, the question of transmission and life-cycle of
B. persica is complex as transovarial transmission of
this infection from the adult female tick via the eggs
to its offspring has been reported [34], and thus this
infection might not need an animal reservoir. Conse-
quently, the roles of animals or humans in the life-
cycle of this pathogen may only be the supply of a
blood meal for the host tick. Despite this, this bacter-
ium is adapted to growth in medium containing hu-
man serum [19] and also to propagation in animals
as shown experimentally in laboratory mice [35].
Therefore, B. persica may easily infect animals and
hence vertebrates may play an important role in its
life-cycle as reservoir hosts.
The tick O. tholozani is typically found in caves, ruins
and archeological sites in Israel where human infection
with B. persica has often been reported to be acquired,
and the disease is frequently referred to as cave fever [9,
11]. Since O. tholozani ticks feed rapidly and do not
commonly attach to their host for more than 20–30 min
[9], ticks are usually not found on human patients and
are also not reported on animal hosts in Israel. There-
fore, it would be unlikely to find cats and dogs infested
with O. tholozani. Furthermore, in perspective of the na-
ture of the tick’s habitat, it seems more probable that
wildlife animals would serve as reservoirs of this infec-
tion, as cats and dogs are not expected to reach remote
cave locations, which are far from their typical environ-
ment. Such potential wildlife reservoirs may nevertheless
be related to dogs or cats, e.g. wild canids such as
jackals, foxes or wolves, or wild feline species.
Although we have documented severe disease with
profound B. persica spirochetemia in dogs and cats,
chronic persistent sub-clinical low level spirochete-
mia undetected by conventional blood smear micros-
copy may exist in animals, which could serve as
reservoirs for tick infection. Such a possibility should
be evaluated by PCR surveys. Such surveys of animal
infection with B. persica could be of public health
importance as animals may serve as sentinels for hu-
man infection.
Conclusions
This study describes severe clinical potentially fatal dis-
ease associated with B. persica infection, a causative
agent of human RF, in domestic cats and dogs. Infection
was associated with lethargy, anorexia, anemia and
thrombocytopenia in both species while fever was more
frequent in infected dogs than in cats. This infection
therefore endangers both humans and domestic carni-
vores, and in the context of One Health, animal infec-
tion may serve as a sentinel for human infection.
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